Amgen Inc. has acquired cancer drug developer Dark Blue Therapeutics Ltd. in a deal worth as much as $840 million, expanding ...

Triple-negative breast cancer (TNBC) is among the most aggressive types of breast cancer, lacking estrogen, progesterone, and ...

Irene Blair was expected to have another six to eight months to live in June, after her pancreatic cancer rapidly advanced to ...

Smart pill bottles may boost adherence to oral breast cancer therapies through daily reminders and tracking, though cost and ...

Researchers discovered a promising leukemia drug breakthrough that could help patients overcome treatment resistance, ...

Scientists are developing magnetically driven nanorobots that can actively navigate the bloodstream and deliver chemotherapy ...

A small number of Canadian cancer patients are testing a pill that contains healthy bacteria from human poop to see if it can extend their lives. They’re taking the plunge. A small number of Canadian ...

July 7, 2025 – The FDA has granted quick approval to a first-of-its-kind pill for a type of lung cancer known as non-small-cell lung cancer (NSCLC). The drug, called sunvozertinib and sold as Zegfrovy ...

Explore the potential of polysaccharide microneedles in cancer immunotherapy for effective drug delivery and immune ...

From hair regrowth to safe pregnancy chemotherapy and new targeted therapies, these top five breast cancer stories of 2025 ...

Hundreds of women with incurable breast cancer have been given "hope of more precious time" after treatment costing £77,000 per year was approved for use on the NHS. The twice-daily pill, capivasertib ...

The moment she heard that her mother, then 67, had advanced breast cancer, Stacie Dusetzina began hunting for potential treatments. A cancer policy researcher at Vanderbilt University, Dusetzina knew ...